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Background: Resistance to multiple classes of insecticides has been detected in the malaria vector Anopheles albimanus
in northwest Peru. Acetylcholinesterase (AChE) insensitivity has previously been associated with resistance to
organophosphate (OP) and carbamate (CA) insecticides in arthropods. A single point mutation on the ace-1 gene
(G119S) associated with resistance to OPs and CAs has been described previously in four anopheline species, but
not in field-collected An. albimanus. The present study aimed to characterize the role of ace-1 in conferring resistance
to both OPs and CAs in the An. albimanus population in Tumbes, Peru.
Methods: The frequency and intensity of resistance to OPs and CAs was quantified through bioassays of female
An. albimanus collected between 2012 and 2014, and the presence of insensitive AChE was confirmed using
biochemical assays. A portion of the ace-1 gene flanking codon 119 was amplified and sequenced from individuals
used in the bioassays and biochemical assays, as well as from historical samples collected in 2008. Statistical analyses
were conducted to determine: (1) associations between genotype and AChE insensitivity; and, (2) associations between
genotype and resistance phenotype.
Results: After confirming high levels of resistance to fenitrothion, malathion, and bendiocarb through bioassays, two
novel polymorphisms were identified at the first and second loci of codon 119, with all individuals from the 2012–2014
collections being heterozygous at the first base (G/T) and either heterozygous (G/C) or homozygous mutants (C/C) at
the second base. Based on sequence data from historical samples, these mutations arose prior to 2008, but became
fixed in the population between 2008 and 2012. Homozygotes at the second locus had significantly higher levels of
AChE insensitivity than heterozygotes (p <0.05). Individuals phenotypically susceptible to OPs and CAs were more likely
to be heterozygous at the second locus (p <0.01). Cloning identified four individuals each containing three distinct
genotypes, suggesting that a duplication of the ace-1 gene may have occurred.
Conclusions: The occurrence of heterozygotes at two loci and the presence of three genotypes in four individuals
suggest that balancing selection could be maintaining OP and CA resistance in this population, while minimizing
associated fitness costs.
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For decades, humans have used insecticides to control
insect pests, including vectors of human pathogens. The
widespread reliance upon and intense use of these che-
micals for public health and agricultural purposes has
led to the development of insecticide resistance in many
insect species [1]. The biochemical and molecular
pathways of resistance vary within organisms and be-
tween chemical groups, providing a complex scenario
with respect to insecticide resistance management and
prevention.
Organophosphates (OPs) are one of the most com-
monly used classes of arthropod adulticides around the
world, including in Latin America. OPs and carbamates
(CAs), another common insecticide, target acetylcholin-
esterase in insects, irreversibly inhibiting the binding of
the enzyme by phosphorylation at the catalytic site [2].
An important indicator of resistance to OPs is the loss
of acetylcholinesterase (AChE) sensitivity [3]. AChE is a
widely distributed enzyme within the nervous system,
which mediates hydrolysis of the neurotransmitter acetyl-
choline throughout the central and peripheral nervous
systems at the postsynaptic membrane through terminat-
ing nerve impulses [4]. Inhibition of the enzyme by an OP
results in the accumulation of acetylcholine, leading to
signs of intoxication and finally death due to respiratory
failure [5,6]. Five mutations on the ace-1 gene were ini-
tially described in OP-resistant insects [7], but in mos-
quito species, only three have been linked to insensitive
AChE mediated resistance: G119S, F290V and F331W
[8-11]. The latter, found in Culex tritaeniorhynchus,
changes the orientation of the catalytic histidine during
hydrolysis, affecting accessibility and interaction with the
H440 catalytic site [8,12]. F290V, identified originally in
Culex pipiens from Cyprus [11], involves a substitution at
the acyl binding pocket and is involved in substrate
specificity [13], likely as a result of hindering the gorge
entrance [14]. The most common mutation, G119S,
identified in several mosquito species, occurs at the
oxyanion hole of the enzyme, resulting in an amino
acid change from glycine to serine leading to a steric
shift, which reduces access of the insecticide to the tar-
get catalytic triad [15].
The G119S substitution has been associated with high
levels of resistance in mosquito vector species, including
field populations of Anopheles gambiae [15-18], Anoph-
eles coluzzii [19] and Culex pipiens sp. [15,18-21], as well
as a laboratory strain of the malaria vector Anopheles
albimanus [18]. The mutation appears to have arisen inde-
pendently at least three times in Cx. pipiens [8,18,20-23],
despite the presence of well-documented fitness costs to
both males and females carrying the mutation. Laboratory
experiments have shown that these fitness costs include
longer development time, reduced overwintering survival,smaller adult size and increased risk of predation [24-28].
However, the cost may be diminished in field populations
as a result of a duplication of the ace-1 gene, which has
been reported in An. gambiae, An. coluzzii, and Cx. pipiens
[17,19,22,23,29]. Previous studies have demonstrated that
having both a mutant and wild type copy of the gene can
reduce fitness costs in both the presence and absence of in-
secticide pressure [17,22,23]. This finding is particularly
troubling with respect to vector control measures, as ef-
forts to manage resistance by removing insecticide pressure
will likely not result in a full recovery of susceptibility in af-
fected populations.
No ace-1 mutations or duplications have been de-
scribed in field populations of An. albimanus, the main
malaria vector in many parts of Central and South
America, including in Tumbes, Peru. In 2012, the
Department of Health in Tumbes discontinued the use
of chemical insecticides to control An. albimanus when
it became clear that the mosquitoes were resistant to
most of the major classes of insecticides used for public
health purposes (Peruvian National Institute of Health,
pers. comm.). However, the local An. albimanus popula-
tion continues to be exposed to insecticides through the
heavy use of agrochemicals in surrounding rice and ba-
nana plantations, and to a lesser extent through the ap-
plication of insecticides to control the dengue vector,
Aedes aegypti.
The present study aimed to further characterize the
role of ace-1 in conferring resistance to both OPs and
CAs in the An. albimanus population in Tumbes, Peru,
as ace-1 mutations can confer cross resistance between
these two chemical groups. Biochemical and bioassay
data were compared with the genotype of individual
mosquitoes to determine how genotypes corresponded
to resistant phenotypes. The results presented herein
identify two previously undescribed non-synonymous
mutations at the first and second base of codon 119,
which are associated with resistance and are likely main-
tained at high levels in the population through a duplica-
tion of the ace-1 gene.
Methods
Mosquito collections
Female An. albimanus were collected from a family farm
in Puerto Pizarro, Tumbes, Peru (3° 30' 10S, 80° 23'
38 W, Figure 1) during three sampling periods: 26–31
August, 2012 (P1), 15–19 April, 2013 (P2) and 7–10
April, 2014 (P3). Individual females were mouth aspirated
from livestock corrals between 17:00 and 21:00 hours on
collection days. Females collected during P1 were mor-
phologically identified to species and immediately stored
at −20°C for biochemical analyses, DNA extraction and
genotyping. Females collected during P2 and P3 were
morphologically identified to species, used in bioassays
Figure 1 Map indicating the study site, located in the Tumbes region of Peru.
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at −20°C for DNA extraction and genotyping. Historical
An. albimanus samples had originally been collected by
the Navy Medical Research Unit – 6 (NAMRU-6) in April
2008 in Puerto Pizarro, and had either been stored in
ethanol (N = 26) or dried (N = 6), and kept at −20°C until
DNA extraction in 2014.
Biochemical assays
Biochemical assays were conducted to assess AChE in-
sensitivity [30]. Abdomens of 77 engorged An. albima-
nus females collected during P1 were excised prior to
homogenization and stored for future molecular ana-
lysis. Either the full body (for mosquitoes not containing
bloodmeals) or the head and thorax (for engorged mos-
quitoes) of the individual mosquitoes collected during
P1 were homogenized in 100 uL KPO4 buffer (6.6 g di-
basic potassium phosphate, 1.7 g monobasic potassium
phosphate, 1,000 ml dH2O; pH = 7.2) and then diluted
to 100 uL with additional KPO4 buffer. As a negativecontrol, the same homogenization procedure was followed
with mosquitoes from the Sanarate insecticide-susceptible
laboratory strain of An. albimanus. To determine the in-
sensitive AChE activity levels, 100 ul of this homogenate
was added in triplicate to wells on a 96-well plate, followed
by 100 ul ATCH (75 mg acetyl-thio-choline iodide, 21 mg
propoxur, 10 ml acetone, 90 ml KPO4 buffer), then 100 ul
DTNB (13 mg Dithio-bis-2-nitrobenzoic acid, 100 ml
KPO4 buffer). The plate was read immediately using 414-
nm filter on a SpectraMax M5e plate reader (Molecular
Devices), then again at 10 min using the same filter. The
difference between the two readings was the value used
for statistical analysis.
Bottle bioassays
CDC bottle bioassays [31] were conducted on female
An. albimanus collected during P2 and P3. A modifica-
tion of the CDC bottle bioassay in which mosquitoes
were exposed to one, two, five and ten times the diag-
nostic dose of insecticide was used to assess resistance
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WHO criteria: 98-100% mortality at 30 min indicates
susceptibility, 90-97% mortality suggests the possibility of
resistance and <90% mortality suggests the presence of
resistance [32].
During P2, bottles were treated with 50 (diagnostic
dose), 100, 250 or 500 ug/bottle of either fenitrothion or
malathion, two commonly used OPs. During P3, fenitro-
thion was tested as during P2, and a standard bottle bio-
assay for the CA bendiocarb was conducted, using the
diagnostic dose of 50 ug/bottle. Each replicate also in-
cluded an untreated control bottle. For both periods,
bioassays were run with two different endpoints: (1)
mosquitoes were exposed to the insecticide for 120 min
with recordings of knock down at 15-min intervals; and,
(2) mosquitoes were exposed for 30 min and then re-
moved, classified as susceptible or resistant, and used for
molecular analyses.
DNA extraction and ace-1 amplification
DNA was extracted from the excised abdomens of the
mosquitoes collected during P1 using the method de-
scribed by Collins et al. [33], and samples were eluted in
25 uL of TE buffer. The full bodies of the historical sam-
ples as well as the mosquitoes collected during P2 and
P3 were homogenized in 180 uL phosphate buffered sa-
line (PBS) and extracted using DNeasy Blood and TissueFigure 2 Analysis of acetylcholinesterase insensitivity in Anopheles al
Sanarate-susceptible Anopheles albimanus strain (control), as measureKits (Qiagen) per the manufacturer’s instructions, and were
eluted to a final volume of 100 uL. All extracted samples
were stored at −20°C prior to DNA amplification.
Anopheles albimanus-specific primers were designed
to amplify the region of the ace-1 gene containing
codon 119 (AAace1F 5’ TGTGGAACCCAAATACGC’3
and AAace1R 5‘ACGTTCTCTTCCGAGGCG’3). The
PCR reaction contained a final volume of 25 uL: 2.5 uL
5X Taq DNA polymerase buffer (Promega), 250 uM
deoxynucleoside triphosphate, 1U Taq DNA polymer-
ase (Promega), 10 pmol of each primer and 50 ng of
DNA template. Cycling conditions included an initial
denaturation step at 94°C for 5 min, followed by 30 cycles
of 94°C for 30 sec, 60°C for 30 sec and 72°C for 60 sec,
and a final extension at 72°C for 5 min. Amplicons were
visualized by electrophoresis on a 2% agarose gel stained
with ethidium bromide.
Sequencing and cloning
Amplicons were purified using a Multiscreen PCR 96-
well plate (Millipore) per the manufacturer’s instructions
and were sequenced directly using primers AAace1F and
AAace1R on an Applied Biosystems 3500xL Genetic
Analyzer (Applied Biosystems). Purification prior to se-
quencing was performed using Applied Biosystems BigDye
XTerminator Purification Kit, per manufacturer’s instruc-
tions (Applied Biosystems). Genotypes were analysedbimanus collected in 2012 from Tumbes, Peru as compared to the
d by AChE activity in the presence of an inhibitor (propoxur).
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LaserGene 11.0 suite. Three phenotypically susceptible
individuals (KCC, KSC(1) and KSC(2)) and three pheno-
typically resistant individuals (KSC(3), KSC(4), KSC(5))
were selected for cloning, using the pGem cloning kit
(Promega) and following the manufacturer’s protocol.
Between seven and 15 clones for each individual were
amplified, purified, sequenced directly, and analysed.Data analyses
Genotype and biochemical assay
T-tests were conducted to determine if an association
existed between insensitive AChE activity and the geno-
type of individual mosquitoes collected during P1.Genotype and phenotype
Independent Chi-square tests were conducted to iden-
tify associations between susceptible and resistant phe-
notypes and the genetic profile at codon 119 of
individual mosquitoes collected during P2 and P3. All
statistical analyses were conducted using the R project
for statistical computing.Figure 3 Results of bottle bioassays for malathion and fenitrothion (P
diagnostic dose and multiples thereof.Results
Biochemical analyses
Significant AChE insensitivity was detected in the field-
collected mosquitoes (mean change in absorbance =
0.083), as compared with the Sanarate-susceptible control
strain (mean = 0.00, p <0.01, Figure 2).Intensity bottle bioassays
During P2, 272 mosquitoes were exposed to varying
doses of fenitrothion (1× the diagnostic dose, n = 58; 2×
the diagnostic dose, n = 65; 5× the diagnostic dose, n =
82 and 10× the diagnostic dose, n = 67), and 229 were
exposed to varying doses of malathion (1×, n = 64; 2×, n =
53; 5×, n = 57 and 10×, n = 55). Bioassay results showed
high levels of both resistance frequency and intensity for
both OPs in this An. albimanus population (Figure 3).
During P3, 282 mosquitoes were exposed to varying
doses of fenitrothion (1×, n = 70; 2×, n = 73; 5×, n = 76;
10×, n = 63). As during P2, resistance was confirmed at
ten times the diagnostic dose of fenitrothion, but had in-
creased from 82.1% mortality in P2 to 50.8% in P3 (Fig-
ure 4). Interestingly, resistance across all intensity levels
was even (approximately 50% mortality), suggesting that2, 2013). Percent mortality at the diagnostic time (30 min) to the
Table 1 Total number and percentage of each genotype
at codon 119 from the population sampled during each
year; K = G/T, S = G/C
Genotype 2008 2012 (P1) 2013 (P2) 2014 (P3)
GGC (WT) 4 (12.5%) 0 (0%) 0 (0%) 0 (0%)
KSC 22 (68.8%) 63 (81.8%) 126 (67.0%) 136 (71.6%)
KCC 4 (12.5%) 14 (18.2%) 62 (33.0%) 54 (28.4%)
GSC 2 (6.3%) 0 (0%) 0 (0%) 0 (0%)
Total 32 77 188 190
Figure 4 Results of bottle bioassays for fenitrothion and bendiocarb (P3, 2014). Percent mortality at the diagnostic time (30 min) to the
diagnostic dose of bendiocarb and multiples of the diagnostic dose of fenitrothion.
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present, is of great intensity. Ninety-seven mosquitoes
were exposed to the diagnostic dose of bendiocarb, identi-
fying significant resistance to this insecticide (33% mortal-
ity, Figure 4).
Ace-1 amplification, sequencing, and cloning
The region including codon 119 of the ace-1 gene was
amplified from 487 female An. albimanus: 32 from 2008,
77 from P1, 188 from P2 (79 susceptible to fenitrothion,
39 resistant to fenitrothion, 55 susceptible to malathion
and 15 resistant to malathion) and 190 from P3 (38 sus-
ceptible to fenitrothion, 52 resistant to fenitrothion, 35
susceptible to bendiocarb and 65 resistant to bendio-
carb). The resulting 139 bp amplicons were purified and
sequenced to determine genetic profile.
Sequencing of historical samples from 2008 yielded
four distinct profiles: wild type (WT; GGC, coding for
glycine), second base heterozygotes (GSC, coding for ei-
ther WT glycine or alanine; S = G/C), first and second
base heterozygotes (KSC, coding for glycine, serine, ala-
nine, or cysteine; K = G/T) and first base heterozygote/
second base mutant (KCC, coding for serine or alanine)
(Table 1). This is the first report of a non-synonymousmutation at either the first or second base of codon 119
in An. albimanus. Sequencing of individuals from P1, P2
and P3 identified only two of these genotypes: KSC and
KCC, and all individuals were heterozygous at the first
base (Table 1). The proportion of mosquitoes homozy-
gous mutant at the second base increased significantly
from 2012 to 2013 (from 18.2 to 33%, p = 0.02).
Clones were sequenced from one individual that was
homozygous mutant at the second base and five individ-
uals that were heterozygous at the second base, identify-
ing three genotypes at codon 119 (Table 2). For the
second-base homozygous individual, six clones coded
for serine at position 119, the known resistant genotype,
Table 2 Codon 119 genotypes of three cloned
phenotypically susceptible (KCC, KSC(1), KSC(2)) and











KCC 0 6 2 0
KSC(1) 4 3 0 0
KSC(2) 5 4 2 0
KSC(3) 3 9 3 0
KSC(4) 3 8 3 0
KSC(5) 4 6 3 0
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base heterozygous individual (KSC(1)) yielded four (WT)
glycine clones and three serine clones. The second
phenotypically susceptible second-base heterozygote
(KSC(2)) and all of the phenotypically resistant individ-
uals (KSC(3), KSC(4), KSC(5)) yielded clones of glycine,
serine and alanine (Table 2). The detection of three dis-
tinct genotypes in four individuals suggests that a dupli-
cation of the ace-1 gene has occurred in this population
of An. albimanus.Figure 5 Average activity of insensitive acetylcholinesterase (iAChE) f
at the second base of codon 119. Significantly greater insensitivity was dData analyses
Genotype and AChE insensitivity
T-tests comparing the activity of insensitive AChE in
KSC (second base heterozygote) and KCC (second base
homozygote mutant) individuals showed significantly
higher AChE insensitivity in KCC individuals (Figure 5,
p <0.05).
Phenotype and genotype
Chi-square tests conducted on genotype and bioassay
data from P2 samples indicated that significantly more
individuals susceptible to any dose of malathion or feni-
trothion were heterozygous at the second base, suggest-
ing that heterozygotes at both bases may have increased
susceptibility (Table 3a, p <0.05). The relatively equal
proportion of resistant individuals that were heterozy-
gous or homozygous at the second locus indicates that
the novel polymorphism may confer increased suscepti-
bility, though it does not appear to increase resistance.
Identical analyses were conducted with the P3 sam-
ples, and similar results were obtained for all intensities
of fenitrothion (Table 3b and c, p < 0.05) and the diag-
nostic dose of bendiocarb (Table 3d, p <0.05). When the
same individuals from the fenitrothion assays were ana-
lysed with respect to the intensity of resistance, the same
pattern held true, with the exception of the diagnosticor individuals that were heterozygous (G/C) vs homozygous (C/C)
etected in homozygotes (p < 0.05).
Table 3 Genotype at the second locus of codon 119 by
resistance phenotype, for (a) P2 (malathion and
fenitrothion), (b) P3 (fenitrothion) (c) by intensity of







Susceptible 99(73.9%) 35(26.1%) 134(100%)
Resistant 27(50.0%) 27(50.0%) 54(100%)
(b)
Susceptible 34(89.5%) 4(10.5%) 38(100%)
Resistant 31(59.6%) 21(40.4%) 52(100%)
(c)
1x diagnostic dose
Susceptible 3(75.0%) 1(25.0%) 4(100%)
Resistant 12(63.2%) 7(36.8%) 19(100%)
2x diagnostic dose
Susceptible 6(100%) 0(0%) 6(100%)
Resistant 10(62.5%) 6(37.5%) 16(100%)
5x diagnostic dose
Susceptible 11(84.6%) 2(15.4%) 13(100%)
Resistant 6(60.0%) 4(40.0%) 10(100%)
10x diagnostic dose
Susceptible 14(93.3%) 1(6.7%) 15(100%)
Resistant 3(42.9%) 4(57.1%) 7(100%)
(d)
Susceptible 30(85.7%) 5(14.3%) 35(100%)
Resistant 41(63.1%) 24(36.9%) 65(100%)
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equally likely to be heterozygous or homozygous at the
second locus (Table 3c, p = 0.317). However, this result
could be due to the low sample size (n = 4) for suscep-
tible individuals at this dose.Discussion
OP and CA insecticides have been used for many years
around the world for the control of malaria vectors.
With OP and CA resistance now being reported in sev-
eral important vector species, understanding the mecha-
nisms underlying this resistance is essential to guide the
use of these chemicals and preserve their efficacy as vec-
tor control tools. Depending on how resistance arises,
discontinuing the use of OPs and CAs may result in a
return to susceptibility in the population over time
[24,25,34,35]. The results of this study suggest that An.
albimanus is adapting to maintain high levels of resistance
to OPs and CAs in Tumbes, Peru, providing a worrisome
scenario from a resistance management perspective.Resistance to OPs and CAs in An. albimanus has previ-
ously been associated with insensitive AChE [30,36-39].
The G119S mutation had previously been reported in an
OP-resistant laboratory strain of An. albimanus [15], but
in the Tumbes population, this serine substitution was not
related to the previously reported single point mutation.
Instead, the high degree of OP and CA resistance was as-
sociated with two previously undescribed polymorphisms
at the first and second loci of codon 119. The polymorph-
ism at the first locus, G/G to G/T, arose prior to 2008 and
has subsequently become fixed in the population. The G-
C substitution at the second locus also appeared prior to
2008, and may possibly be moving toward fixation, with
an increase in C homozygotes from 18.2 to 28.2% detected
between 2012 and 2014. Data from historical samples sug-
gest that this novel substitution at the second locus may
have arisen prior to the substitution at the first locus,
which is in contrast to the findings of previous studies,
which have only identified a mutation at the first locus.
The majority of individuals from the 2008 collection
(~80%) were heterozygous at the first base of codon 119.
However, the genotypes of two individuals from 2008
were heterozygous at base 2, but homozygous wild type
at base 1. This was unexpected, as the possible amino
acids for these individuals are glycine (susceptible) and
alanine, rather than the amino acid associated with re-
sistance, serine. Serine confers resistance by altering the
conformation of the protein and reducing access to the
catalytic triad [18]. If alanine had the same effect, it can
be assumed that all individuals that were heterozygous
at base 1 and homozygous mutant at base 2 would be re-
sistant to OPs and, likely, CAs. However, in both 2013
and 2014, there were individuals homozygous mutant at
base 2 and heterozygous at base 1 that were phenotypic-
ally susceptible to fenitrothion, malathion and bendio-
carb, indicating that any structural changes associated
with alanine may not confer the same level of resistance
as the serine mutation.
Since 2012, the mutant allele at the first base of codon
119 has become fixed in the population, with 100% of
samples heterozygous at this locus. The maintenance of
this polymorphism in the population is likely due to a
duplication of the ace-1 gene, which has previously been
reported in the malaria vectors An. gambaie, An. coluzzii
and Cx. pipiens [17,22,29,40]. In the present study, the
detection of three genotypes in four individuals provides
the first evidence that an ace-1 gene duplication may
have occurred in a field population of An. albimanus. If
present, this duplication would allow individuals to have
both susceptible and resistant copies of the gene, which
likely decreases fitness costs associated with the resistant
genotype. This has been observed in Cx. pipiens popula-
tions that have undergone a recent ace-1 mutation and
duplication event [22,23,41], and has likely evolved in
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mechanism, which has recently been implicated in the
maintenance of other alleles associated with insecticide
resistance [42], allows for the maintenance of genetic
polymorphisms in a population while minimizing associ-
ated fitness costs. In such a scenario, heterozygotes have
an advantage in that they contain both the resistant and
wild type alleles, and as such, they are able to survive in-
secticide exposure but at a reduced cost to their overall
fitness when compared with individuals that have only
the resistant allele.
The intensive use of agrochemicals in the Tumbes re-
gion will likely provide this population with constant ex-
posure to a variety of insecticides. The role that these
agricultural chemicals play in the development and
maintenance of resistance has been discussed with re-
spect to African malaria vectors [43-45], and similar sce-
narios are clearly present in Latin America as well. The
rotation of different chemicals throughout the year to
control various crop pests results in the inadvertent ex-
posure of malaria vectors to different insecticide groups,
often at low and/or sub-lethal doses. Unfortunately, the
regulation of agricultural insecticide use is challenging
to implement and enforce, and it therefore seems un-
likely that this source of insecticide selection pressure
will change.
Conclusions
This study presents the first evidence of two previously
undescribed mutations associated with high levels of re-
sistance to OP and CA insecticides in a field population
of An. albimanus, potentially maintained in the popula-
tion by a duplication of the ace-1 gene. Data from his-
torical samples suggest that the mutation at the second
locus of codon 119 may have arisen prior to the muta-
tion at the first locus. From 2012 to 2014 there was an
increase in the number of homozygotes at the second
locus, indicating that the mutant allele may be moving
toward fixation in the population. If this is the case, the
wild type susceptible genotype will no longer exist in
this population and resistance will likely be irreversible.
In the absence of efforts to decrease the insecticide pres-
sure on this population, its susceptibility to two key classes
of chemical insecticides used for malaria vector control is
likely to be lost.
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